Protagenic Therapeutics, Inc.
Protagenic Therapeutics, Inc. (PTIX) Stock Overview
Key statistics and deep links to earnings, valuation, revenue, dividends, and more.
FMP · PTIX · as of Jun 9, 2026
Key Statistics
Explore Protagenic Therapeutics, Inc. Data
ptix stock data · financialsFinancial Snapshot
Full FinancialsAnalyst Ratings & Price Target
Full ForecastTotal: 1 · Buy rate: 100.0%
Competitors & Peers
ptix competitorsPTIX
ARTL
CARM
GTBP
INDP
LIPOStock Performance
Full HistoryAbout Protagenic Therapeutics, Inc.
Protagenic Therapeutics, Inc. operates as a biopharmaceutical firm dedicated to the research and development of novel treatments designed to address neuropsychiatric and mood conditions exacerbated by…
what is protagenic therapeutics, inc. · ptix stock overview · protagenic therapeutics, inc. company profile · who is protagenic therapeutics, inc. ceo · ptix NASDAQ · protagenic therapeutics, inc. headquarters · protagenic therapeutics, inc. business segments
About Stock Overview & Key Data
Protagenic Therapeutics, Inc. (PTIX) is a Healthcare company in the Biotechnology industry, listed on NASDAQ since Apr 27, 2021. As of the latest trading session, PTIX stock price is $0.50, with a market capitalization of $905,104. The stock has returned -86.26% over the past 12 months and -61.54% year-to-date.
According to 1 Wall Street analysts, the consensus rating for Protagenic Therapeutics, Inc. stock is Buy, with an average 12-month price target of $—. In fiscal year 2025, Protagenic Therapeutics, Inc. reported revenue of — and net income of -$5.2M. For detailed data — including Protagenic Therapeutics, Inc. revenue history, earnings, dividends, and PE ratio — use the tabs above.
Frequently Asked Questions
As of the latest trading session, Protagenic Therapeutics, Inc. (PTIX) stock price is $0.50. The stock is traded on NASDAQ under the ticker symbol PTIX. The 52-week range is $0.25 – $6.20.